Siobhan Mitchell is the Chief Scientific Officer at MitoQ. She completed her PhD at SUNY Albany and a post-doctoral fellowship on brain aging at University of Washington. Siobhan held roles at the three largest food companies in the world (Unilever, Nestle and Pepsico), leading trials in Europe, North America and Asia, which investigated the effects of nutrition on cognitive decline, mood and performance. Additionally, she was senior director at Noom, where she directed a team investigating weight loss and mental health digital programs using cognitive behaviour therapy methods.
Siobhan has given talks on nutritional neuroscience at conferences all over the world. She’s authored over 80 papers, and holds eight patents for aging, cognition and mood products.
Cellular health is the cornerstone of longevity science, and mitochondrial decline—as the cell's energy hub—is one of the core hallmarks of aging. As nutritional intervention enters the molecular era, bypassing biological barriers to achieve precision intervention for specific organelles has become the key to extending healthspan.
What are the core mechanisms of mitochondrial targeting technology? How can scientific innovation be transformed into tangible consumer value? These are the essential questions that brands and products must answer in this new era of cellular health.